Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
152M
-
Number of holders
-
212
-
Total 13F shares, excl. options
-
118M
-
Shares change
-
+486K
-
Total reported value, excl. options
-
$4B
-
Value change
-
-$423K
-
Put/Call ratio
-
0.95
-
Number of buys
-
99
-
Number of sells
-
-88
-
Price
-
$33.99
Significant Holders of Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT) as of Q3 2021
252 filings reported holding ADPT - Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share as of Q3 2021.
Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT) has 212 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 118M shares
of 152M outstanding shares and own 77.59% of the company stock.
Largest 10 shareholders include VIKING GLOBAL INVESTORS LP (30M shares), Matrix Capital Management Company, LP (11.6M shares), PRICE T ROWE ASSOCIATES INC /MD/ (11.4M shares), VANGUARD GROUP INC (11M shares), BlackRock Inc. (5.59M shares), ARK Investment Management LLC (4.86M shares), Neuberger Berman Group LLC (2.25M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (2.22M shares), Capital International Investors (2.09M shares), and Sumitomo Mitsui Trust Holdings, Inc. (2.06M shares).
This table shows the top 212 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.